Sign In

Jeffrey Low

Series A Investor at Erasca, Inc.

Principal at Novo Growth. Investing in the next generation of life sciences companies at the largest biotech investor in the world. Previously @a16z

Highlights

Aug 8 · linkedin

Excited to share that Recursion and portfolio company Exscientia have agreed to merge!

This merger brings together Exscientia’s generative AI chemistry platform with Recursion’s high throughput target discovery capabilities to create the clear leader in AI drug discovery.

Congrats to long-time friends on both teams!

May 22 · linkedin

Congratulations Travis Murdoch, MD, Paul Berns and Carol Suh at ARCH Venture Partners, and the Hi-Bio team!

Related Questions

What is Jeffrey Low's current role?
Where is he a Principal?
What is his educational background?
Which companies has he served as a board observer for?
Jeffrey Low
Add to my network

Experience

Board Observer at Omada Health
Board Observer at Cardiogram

Education

Convent & Stuart Hall
Stuart Hall High School
Doctor Of Medicine In Medicine, Yale University School Of Medicine
Master Of Business Administration, Harvard Business School
Bachelor Of Arts In Biology, Government, Harvard University

Location

San Francisco, California, United States